Results 131 to 140 of about 1,831 (172)
Fertility and Sterility, 2004 OBJECTIVE: To determine the role of an aromatase inhibitor, letrozole, in the treatment of reproductive-age women with endometriosis and associated chronic pelvic pain. DESIGN: Phase 2, open-label, nonrandomized proof-of-concept study.
Bilgin Gürates, Serdar E Bulun
exaly +1 more source
Human Reproduction, 1996 A protocol utilizing both leuprolide acetate (LA) and norethindrone acetate (NETA) in subjects undergoing ovarian suppression prior to follicle aspiration proved more effective than LA alone in reducing the incidence of ovarian cyst formation without ...
Edward C Ditkoff, Mark V Sauer
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Endocrinologica, 1982
Abstract. The metabolic clearance rate (MCR) of norethindrone acetate1 (NETA) and norethindrone (NET) levels in plasma were studied after an iv injection of [3H]NETA in three women before and at 1 week, 1, 2 and 6 months following the insertion of a single silastic subdermal implant releasing microquantities of NETA. No significant change in the MCR of
H, Singh +6 more
openaire +2 more sources
Abstract. The metabolic clearance rate (MCR) of norethindrone acetate1 (NETA) and norethindrone (NET) levels in plasma were studied after an iv injection of [3H]NETA in three women before and at 1 week, 1, 2 and 6 months following the insertion of a single silastic subdermal implant releasing microquantities of NETA. No significant change in the MCR of
H, Singh +6 more
openaire +2 more sources
Norethindrone in Serum After use of an oral Contraceptive Containing Norethindrone Acetate
Acta Obstetricia et Gynecologica Scandinavica, 1983Abstract. The availability of norethindrone (NET) in serum was studied in 8 women after daily administration of a combination oral contraceptive pill (MinovlarR) containing 1 mg norethindrone acetate (NETA) and 50 μg ethinyl estradiol (EE2) from day 5 to day 25 of the menstrual cycle. The pill was taken daily at 9.30 a.m.
N N, Sarkar +4 more
openaire +2 more sources
Clinical evaluation of norethindrone acetate in fertility control
American Journal of Obstetrics and Gynecology, 1965A clinical evaluation of 300 Mexican women accumulating 5902 treatment cycles representing 454 woman-years with 4 mg norethindrone acetate and .05 mg ethinyl estradiol (Anovlar) is presented. Each woman was instructed to take 1 tablet daily for 20 consecutive days beginning on Cycle Day 5. Anovlar was virtually 100% effective.
E, RICE WRAY +5 more
openaire +2 more sources
Contraception, 1991
Subdermal silastic implants releasing norethindrone acetate were inserted in five rhesus monkeys for a period of seven months. The serum norethindrone (NET) levels were estimated from blood samples collected fortnightly. There was an initial high level of NET followed by fluctuating levels of NET in 4 out of five monkeys.
P, Jha, K, Murugesan, A, Farooq
openaire +2 more sources
Subdermal silastic implants releasing norethindrone acetate were inserted in five rhesus monkeys for a period of seven months. The serum norethindrone (NET) levels were estimated from blood samples collected fortnightly. There was an initial high level of NET followed by fluctuating levels of NET in 4 out of five monkeys.
P, Jha, K, Murugesan, A, Farooq
openaire +2 more sources
Contraception, 1978
A specific radioimmunoassay was developed for the estimation of norethindrone levels in the serum of lactating women. A conjugate of norethindrone-3-BSA was synthesized and antiserum raised against it in rabbits. The antiserum showed high affinity (1.5 x 10(9)M/L) and titer and was specific. The sensitivity of the assay was 125 pg/ml serum.
V, Laumas +6 more
openaire +2 more sources
A specific radioimmunoassay was developed for the estimation of norethindrone levels in the serum of lactating women. A conjugate of norethindrone-3-BSA was synthesized and antiserum raised against it in rabbits. The antiserum showed high affinity (1.5 x 10(9)M/L) and titer and was specific. The sensitivity of the assay was 125 pg/ml serum.
V, Laumas +6 more
openaire +2 more sources
A Contraceptive Vaginal Ring Releasing Norethindrone Acetate and Ethinyl Estradiol
Obstetrical & Gynecological Survey, 1994A core design contraceptive vaginal ring (CVR) releasing 650 mcg of norethindrone acetate (NA) and 10, 20, 30 or 65 mcg of ethinyl estradiol (EE) daily was developed and tested in 99 women. The CVR inhibited ovulation well with 30 or 65 mcg EE. Vaginal bleeding was better controlled than in 23 control women using NA/EE oral contraceptives. Side effects
S A, Ballagh +5 more
openaire +2 more sources
Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles
Human Reproduction, 1989Twenty patients were given norethindrone acetate (NET) to program the initiation of controlled ovarian hyperstimulation and to coordinate follicular aspiration with surgery to obtain spermatozoa from the husband. Patients received NET, 10 mg/day orally, starting between days 2 and 4 of the cycle.
GERLI, Sandro +6 more
openaire +4 more sources
Pharmacology and Toxicology of Ethinyl Estradiol and Norethindrone Acetate in Experimental Animals
Regulatory Toxicology and Pharmacology, 2001For over 30 years various combinations of synthetic estrogens and progestins have been used in oral contraceptive formulations. Ethinyl estradiol (EE) and norethindrone acetate (NA) are common synthetic hormones used in oral contraceptives such as Loestrin, Brevicon, Ortho-Novum, Norlestrin, and Norinyl.
W E, Maier, J R, Herman
openaire +2 more sources